A new study published in the New England Journal of Medicine reveals that Pfizer’s mRNA-based flu vaccine, known as modRNA, has outperformed traditional flu...
A recent clinical trial has revealed that Eli Lilly’s once-weekly insulin, efsitoria, offers comparable glycemic control to the traditional daily insulin glargine for patients...